Related Experiment Video
Updated: Oct 31, 2025

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
Systemic Analysis of the DNA Replication Regulator MCM Complex in Ovarian Cancer and Its Prognostic Value
Yukun Li1, Juan Zou1, Qunfeng Zhang1
1Department of Obstetrics and Gynecology, The Second Affiliated Hospital of University of South China, Hengyang, China.
Abstract:
Microliposome maintenance (MCM) 2, MCM3, MCM4, MCM5, MCM6, and MCM7 are DNA replication regulators and are involved in the progression of multiple cancer types, but their role in ovarian cancer is still unclear. The purpose of this study is to clarify the biological function and prognostic value of the MCM complex in ovarian cancer (OS) progression. We analyzed DNA alterations, mRNA and protein levels, protein structure, PPI network, functional enrichment, and prognostic value in OC based on the Oncomine, cBioPortal, TCGA, CPTAC, PDB, GeneMANIA, DAVID, KEGG, and GSCALite databases. The results indicated that the protein levels of these DNA replication regulators were increased significantly. Moreover, survival analysis showed a prognostic signature based on the MCM complex, which performed moderately well in terms of OS prognostic prediction. Additionally, protein structure, functional enrichment, and PPI network analyses indicated that the MCM complex synergistically promoted OC progression by accelerating DNA replication and the cell cycle. In conclusion, our study suggested that the MCM complex might be a potential target and prognostic marker for OC patients.
Insights
The Microliposome maintenance (MCM) complex, a DNA replication regulator, is elevated in ovarian cancer. This MCM complex shows potential as a prognostic marker and therapeutic target for ovarian cancer patients.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Microliposome maintenance (MCM) 2-7 proteins regulate DNA replication and are implicated in various cancers.
- The specific role of the MCM complex in ovarian cancer (OC) progression remains largely uncharacterized.
Purpose of the Study:
- To elucidate the biological functions of the MCM complex in ovarian cancer.
- To determine the prognostic significance of the MCM complex in ovarian cancer patients.
Main Methods:
- Analysis of DNA alterations, mRNA, and protein expression using databases like TCGA and CPTAC.
- Investigation of protein structure, protein-protein interaction (PPI) networks, and functional enrichment.
- Prognostic value assessment using survival analysis and GSCALite.
Main Results:
- Significantly elevated protein levels of MCM complex members were observed in ovarian cancer.
- A prognostic signature derived from the MCM complex demonstrated moderate predictive performance for overall survival (OS) in OC.
- Functional analyses indicated the MCM complex promotes OC progression by enhancing DNA replication and cell cycle.
Conclusions:
- The MCM complex plays a synergistic role in promoting ovarian cancer progression.
- The MCM complex represents a potential therapeutic target and prognostic biomarker for ovarian cancer.
More Related Videos
Related Concept Videos
DNA Helicases
Restarting Stalled Replication Forks
Abnormal Proliferation
S-Cdk Initiates DNA Replication
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of...
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle

